Real-world healthcare costs and resource utilization (HRU) among patients treated with erenumab in the United States: A retrospective claims database study

被引：0
|
作者：
Tepper, S. J. [1 ]
Schwedt, T. J. [2 ]
Vo, P. [3 ]
Joshi, P. [4 ]
Glassberg, M. [5 ]
Abdrabboh, A. [5 ]
Ferraris, M. [3 ]
Tiwari, S. [4 ]
Thompson, J. [6 ]
机构：
[1] Dartmouth Hitchcock Dept Neurol, Geisel Sch Med, Hanover, NH USA
[2] Mayo Clin, Phoenix, AZ USA
[3] Novartis Pharma AG, Basel, Switzerland
[4] Novartis Healthcare Private Ltd, Value & Access, Hyderabad, Telangana, India
[5] Novartis Pharmaceut, E Hanover, NJ USA
[6] Kantar Hlth, New York, NY USA
来源：
JOURNAL OF HEADACHE AND PAIN | 2021年 / 22卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
AL050
引用
收藏
页码：17 / 18
页数：2
相关论文
共 50 条
  • [31] Understanding real world treatment patterns, healthcare resource utilization (HRU) and costs among metastatic renal cell carcinoma (mRCC) patients
    Copher, R.
    Byfield, S. Dacosta
    Buzinec, P.
    Korrer, S.
    Baig, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [32] All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States
    Mostaghimi, Arash
    Gandhi, Kavita
    Done, Nicolae
    Ray, Markqayne
    Gao, Wei
    Carley, Christopher
    Wang, Travis
    Swallow, Elyse
    Sikirica, Vanja
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (04): : 426 - 434
  • [33] Real world treatment patterns, healthcare resource utilization (HRU), and costs among Waldenstrom macroglobulinemia (WM) patients initiating therapy.
    Ellis, Lorie
    Byfield, Stacey DaCosta
    Korrer, Stephanie
    Schenkel, Brad
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [34] REAL-WORLD HEALTHCARE COSTS IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA TREATED WITH PEMBROLIZUMAB AND NIVOLUMAB IN THE UNITED STATES
    Laliberte, F.
    Raut, M.
    Germain, G.
    Desai, K.
    Nahar, A.
    Yang, X.
    MacKnight, S.
    Duh, M. S.
    VALUE IN HEALTH, 2021, 24 : S5 - S6
  • [35] Real-world treatment patterns, adherence, costs, and healthcare resource utilization associated with Waldenstrom macroglobulinemia in the United States.
    Yang, Keri
    Castillo, Jorge J.
    Ratiu, Anna
    Delinger, Rachel
    Zimmerman, Todd
    Tang, Boxiong
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [36] REDUCTIONS IN REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AMONG UNITED STATES HEREDITARY ANGIOEDEMA (HAE) PATIENTS FOLLOWING BEROTRALSTAT INITIATION
    Christiansen, S.
    Lopez-Gonzalez, L.
    MacKnight, S.
    Laliberte, F.
    Spencer, C.
    Nestler-Parr, S.
    Johnston, D.
    Gillard, P.
    Zuraw, B. L.
    VALUE IN HEALTH, 2024, 27 (06) : S144 - S144
  • [37] Healthcare resource utilization and costs of hepatitis delta in the United States: an analysis of all-payer claims database
    Lim, Joseph
    Rustgi, Vinod
    Gish, Robert G.
    Jacobson, Ira M.
    Kaushik, Ankita
    Liu, Yan
    Acter, Emily
    Wong, Robert
    JOURNAL OF HEPATOLOGY, 2022, 77 : S280 - S280
  • [38] REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION (HRU) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
    Bhanegaonkar, A.
    Gauthier, G.
    Kim, R.
    Vekeman, F.
    Dea, K.
    Robitaille, M. N.
    Moyneur, E.
    Liu, F. X.
    VALUE IN HEALTH, 2020, 23 : S84 - S84
  • [39] Real-world healthcare costs and resource utilization in patients with von Willebrand disease and angiodysplasia
    Connell, N. T.
    Caicedo, J.
    Nieto, N.
    Chatterjee, S.
    Hait, A.
    Gupta, A. K.
    Bullano, M.
    Schultz, B. G.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (06) : 691 - 699
  • [40] Healthcare Utilization and Costs Among Patients with Psoriatic Arthritis and Psoriasis in the United States - a Retrospective Study of Claims Data from 2009 to 2020
    Merola, Joseph
    Villacorta, Reginald
    Dennis, Natalie
    Chakravarty, Soumya
    Mesana, Laura
    Lin, Iris
    Pacou, Maud
    Baker, Thomas
    Wang, Yiting
    Peterson, Steven
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345